Skip to main content
. Author manuscript; available in PMC: 2015 Feb 23.
Published in final edited form as: J Infect Dis. 2006 Nov 21;195(1):134–141. doi: 10.1086/509809

Figure 3.

Figure 3

Proportion of isolates with mutant pfmdr1 alleles in pre- and posttreatment isolates after antimalarial treatment (including reinfections and recrudescences). AL, artemether-lumefantrine; ART, artemisinin monotherapy; MAS3, mefloquine plus 3 days of artesunate; MFQ, mefloquine monotherapy; QU, quinine.